FGFR1 amplification was typically high-level according to our predefined criteria: 67% (12 of 18) FGFR1-amplified ESCC, and 80% (4 of 5) FGFR1-amplified EADC showed high-level amplification. Here, FGFR1 is linked to esophageal squamous cell carcinoma.